Sheets Smith Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $811K | Buy |
1,300
+1
| +0.1% | +$681 | 0.08% | 232 |
|
|
2026
Q1 | $1M | Buy |
1,299
+2
| +0.2% | +$1.53K | 0.11% | 190 |
|
|
2025
Q4 | $1M | Sell |
1,297
-20
| -2% | -$13.6K | 0.11% | 180 |
|
|
2025
Q3 | $741K | Buy |
1,317
+36
| +3% | +$20.4K | 0.08% | 223 |
|
|
2025
Q2 | $673K | Buy |
1,281
+55
| +4% | +$30.7K | 0.08% | 234 |
|
|
2025
Q1 | $778K | Buy |
1,226
+66
| +6% | +$45.4K | 0.1% | 190 |
|
|
2024
Q4 | $826K | Buy |
1,160
+45
| +4% | +$37.8K | 0.1% | 177 |
|
|
2024
Q3 | $1.17M | Hold |
1,115
| – | – | 0.14% | 138 |
|
|
2024
Q2 | $1.17M | Buy |
1,115
+57
| +5% | +$55.3K | 0.14% | 144 |
|
|
2024
Q1 | $1.02M | Buy |
1,058
+601
| +132% | +$571K | 0.11% | 163 |
|
|
2023
Q4 | $401K | Buy |
457
+7
| +2% | +$5.76K | 0.06% | 255 |
|
|
2023
Q3 | $370K | Hold |
450
| – | – | 0.06% | 246 |
|
|
2023
Q2 | $323K | Hold |
450
| – | – | 0.05% | 269 |
|
|
2023
Q1 | $370K | Hold |
450
| – | – | 0.06% | 236 |
|
|
2022
Q4 | $325K | Hold |
450
| – | – | 0.05% | 246 |
|
|
2022
Q3 | $310K | Hold |
450
| – | – | 0.05% | 239 |
|
|
2022
Q2 | $266K | Hold |
450
| – | – | 0.04% | 258 |
|
|
2022
Q1 | $314K | Hold |
450
| – | – | 0.04% | 275 |
|
|
2021
Q4 | $284K | Hold |
450
| – | – | 0.04% | 314 |
|
|
2021
Q3 | $272K | Hold |
450
| – | – | 0.04% | 315 |
|
|
2021
Q2 | $251K | Sell |
450
-65
| -13% | -$32.9K | 0.03% | 323 |
|
|
2021
Q1 | $244K | Hold |
515
| – | – | 0.04% | 298 |
|
|
2020
Q4 | $249K | Buy |
+515
| New | +$278K | 0.04% | 297 |
|
|
2017
Q3 | – | Sell |
-2,395
| Closed | -$1.18M | – | 315 |
|
|
2017
Q2 | $1.18M | Buy |
+2,395
| New | +$1.05M | 0.31% | 89 |
|
Other funds holding REGN
WCM
AIP
AP
HCM
CNB
P